Shire plc (ADR)

NASDAQ: SHPG
$179.20
+$0.00 (+0.0%)
Closing price January 8, 2019
The top analyst upgrades, downgrades and initiations seen on Friday include Apple, Caterpillar, Costco, GW Pharmaceuticals, NXP Semiconductors, Southwest Airlines, Teva Pharmaceutical, Ulta Beauty...
The op analyst upgrades, downgrades and initiations seen on Tuesday include Apple, AT&T, BBVA, Cisco Systems, Dollar Tree, Facebook, Roku, Seagate Technology, Turkcell and Verizon Communications.
Shares of Shire saw a solid gain on Wednesday after the firm announced that it received an offer to be acquired by Takeda Pharmaceutical.
Here are 10 top Ireland-based public companies with shares that are traded in the United States that may be worth putting on a watchlist.
The top analyst upgrades, downgrades and other research calls from Tuesday include Chipotle Mexican Grill, Etsy, Home Depot, PagSeguro, Snap, Walmart and Wingstop.
24/7 Wall St. screened the Stifel specialty pharmaceutical list and found five stock rated Buy that have massive upside potential and probably don’t have the investment risk of some of the more...
Although Shire is not seeing much of a bump in its share price, the firm is creating a lot of value with its most recent submission to the FDA.
These four top companies all have data that could move the shares the rest of this year and into 2018. All have been around for years and will remain sector leaders for years to come.
Here are 10 of the most notable top picks from Credit Suisse in European equities for U.S. investors.
The top analyst upgrades, downgrades and other research calls from Tuesday include Apple, Chesapeake Energy, DowDuPont, Equifax, Gap, Nike, Tesla and Under Armour.
Leon Cooperman is one of the top "whales" from the hedge fund world that investors like to follow. Here are his five picks from Tuesday's conference notes.
A new report from SunTrust Robinson Humphrey indicates big pharmaceuticals may be the place to be for investors. Among the report's top picks: AbbVie, Eli Lilly, Merck, and Shire.
Friday’s top analyst upgrades, downgrades and initiations included Costco, Deckers Outdoor, Qualcomm, Royal Dutch Shell, Shire and Ulta Beauty.
Merrill Lynch has raised its price targets on five quality, large-cap growth stocks that make good sense for growth investors looking to reposition their portfolios to account for perhaps more...
SunTrust Robinson Humphrey feels that the major pharmaceutical companies will outperform the rest of the year, and they cite new products, attractive dividends and solid performance as positives.